Clinical Outcomes of Patients with Diabetes Mellitus and Acute ST-elevation Myocardial Infarction Following Fibrinolytic Therapy: A Nationwide Inpatient Sample (NIS) Database Analysis.

CONCLUSION: Diabetic patients receiving fibrinolytic therapy for STEMI might have higher odds of all-cause mortality and cardiogenic shock compared to non-diabetic patients. PMID: 33567924 [PubMed - as supplied by publisher]
Source: Expert Review of Cardiovascular Therapy - Category: Cardiology Tags: Expert Rev Cardiovasc Ther Source Type: research